文献速递皮肤肿瘤

利用美国国家癌症数据库评估薄黑色素瘤前哨淋巴结阳性的预测因素

Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
PubMed 文献 · J Am Acad Dermatol · 2018-09-18

研究基于美国国家癌症数据库2004至2014年9186例Breslow厚度≤1.00 mm并接受前哨淋巴结活检的皮肤黑色素瘤患者,用逻辑回归分析前哨淋巴结阳性的预测因素。多因素分析显示年龄<60岁、Breslow厚度>0.8 mm、真皮核分裂、溃疡及Clark分级IV至V与阳性风险升高相关。

要点

  • 年龄<60岁和Breslow厚度>0.8 mm与前哨淋巴结阳性风险升高相关。
  • 真皮核分裂使前哨淋巴结阳性比值比增加95%(OR 1.95)。
  • 无溃疡但伴真皮核分裂者前哨淋巴结阳性比值比增加92%(OR 1.92)。

核心结论

  • 年轻年龄、Breslow厚度>0.8 mm、真皮核分裂、溃疡及Clark分级IV至V是前哨淋巴结阳性的正向预测因素。
  • 虽然新的美国癌症联合委员会分期系统已将真皮核分裂率从分期中移除,继续评估真皮核分裂率可能对指导前哨淋巴结活检的手术决策有价值。

研究设计与样本

  • 从美国国家癌症数据库2004年至2014年识别Breslow厚度≤1.00 mm并接受前哨淋巴结活检的皮肤黑色素瘤患者,共9186例,采用逻辑回归分析前哨淋巴结阳性的预测因素。

主要发现

  • 多因素分析中,年龄<60岁(P<.001)和Breslow厚度>0.8 mm(P=.03)与前哨淋巴结阳性风险升高相关。
  • 真皮核分裂使前哨淋巴结阳性比值比增加95%(OR 1.95 [95%CI 1.53-2.5],P<.001)。
  • 溃疡使前哨淋巴结阳性比值比增加63%(OR 1.63 [95%CI 1.21-2.18],P<.001)。
  • Clark分级IV至V使前哨淋巴结阳性比值比增加48%(OR 1.48 [95%CI 1.19-1.85])。
  • 无溃疡但伴真皮核分裂者前哨淋巴结阳性比值比增加92%(OR 1.92 [95%CI 1.5-2.48],P<.001)。

局限性

  • 原文报告生存数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sentinel lymph node biopsy (SLNB) specimens are often obtained from patients for further staging after these patients have undergone melanoma excision. Limited data regarding predictors of SLNB positivity in thin melanoma are available. OBJECTIVE: We sought to evaluate predictors of SLNB positivity in thin melanoma. METHODS: Patients with cutaneous melanoma with a Breslow thickness ≤1.00 mm who received a SLNB were identified from the National Cancer Database between 2004 and 2014 (n = 9186). Predictors of SLNB positivity were analyzed using logistic regression. RESULTS: In a multivariate analysis, patients <60 years of age (P < .001) and Breslow thickness >0.8 mm (P = .03) were at increased risk for positive sentinel lymph node (SLN). Moreover, on multivariate analysis, the presence of dermal mitoses increased the odds of SLN positivity by 95% (odds ratio [OR] 1.95 [95% confidence interval {CI} 1.53-2.5], P < .001), ulceration by 63% (OR 1.63 [95% CI 1.21-2.18], P < .001), and Clark level IV to V by 48% (OR 1.48 [95% CI 1.19-1.85]). Patients without ulceration but with dermal mitoses had 92% (OR 1.92 [95% CI 1.5-2.48], P < .001) increased SLN positivity. LIMITATIONS: Limited survival data are available. CONCLUSIONS: Younger age, a Breslow thickness >0.8 mm, the presence of dermal mitoses, ulceration, and Clark level IV to V are positive predictors of positive SLN. While the new American Joint Committee on Cancer system has removed dermal mitotic rate from staging, continued evaluation of dermal mitotic rate could be valuable for guiding surgical decision making about SLNB.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Conic RRZ, Ko J, Damiani G, et al. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database. J Am Acad Dermatol. 2018. PMID: 30240775. doi:10.1016/j.jaad.2018.08.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。